The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning.

Autor: McGee KP; Department of Radiology, Mayo Clinic & Foundation, Rochester, Minnesota, USA., Cao M; Department of Radiation Oncology, University of California, Los Angeles, California, USA., Das IJ; Department of Radiation Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Yu V; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Witte RJ; Department of Radiology, Mayo Clinic & Foundation, Rochester, Minnesota, USA., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, California, USA., Valle LF; Department of Radiation Oncology, University of California, Los Angeles, California, USA., Wiesinger F; GE HealthCare Global Research, Munich, Germany., De-Colle C; Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany., Cao Y; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan, USA., Breen WG; Department of Radiation Oncology, Mayo Clinic & Foundation, Rochester, Minnesota, USA., Traughber BJ; Department of Radiation Oncology, Mayo Clinic & Foundation, Rochester, Minnesota, USA.
Jazyk: angličtina
Zdroj: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Nov; Vol. 60 (5), pp. 1786-1805. Date of Electronic Publication: 2024 Jan 24.
DOI: 10.1002/jmri.29246
Abstrakt: Ever since its introduction as a diagnostic imaging tool the potential of magnetic resonance imaging (MRI) in radiation therapy (RT) treatment simulation and planning has been recognized. Recent technical advances have addressed many of the impediments to use of this technology and as a result have resulted in rapid and growing adoption of MRI in RT. The purpose of this article is to provide a broad review of the multiple uses of MR in the RT treatment simulation and planning process, identify several of the most used clinical scenarios in which MR is integral to the simulation and planning process, highlight existing limitations and provide multiple unmet needs thereby highlighting opportunities for the diagnostic MR imaging community to contribute and collaborate with our oncology colleagues. EVIDENCE LEVEL: 5 TECHNICAL EFFICACY: Stage 5.
(© 2024 International Society for Magnetic Resonance in Medicine.)
Databáze: MEDLINE
Externí odkaz: